Patents by Inventor Peter Seither

Peter Seither has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PIPERIDYL-PROPANE-THIOL CCR3 MODULATORS
    Publication number: 20100317634
    Abstract: One object of the present invention are novel substituted piperidyl-propane-thiols of the formula (1), wherein R1, R2, R3 and R4 are defined as below. Another object of the present invention is to provide agonists or antagonists of CCR-3, or pharmaceutically acceptable salts thereof, more particularly to provide pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one of the compounds of the present invention or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 25, 2007
    Publication date: December 16, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Domnic Martyres, Matthias Hoffmann, Peter Seither, Thierry Bouyssou
  • SUBSTITUTED PIPERIDINES AS CCR3 ANTAGONISTS
    Publication number: 20100261687
    Abstract: Object of the present invention are novel substituted compounds of the formula 1, wherein A, R1, R2, R3 and R4 are defined as in the description. Another object of the present invention is to provide antagonists of CCR3, more particularly to provide pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one of the compounds of the present invention or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 19, 2010
    Publication date: October 14, 2010
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Marc GRUNDL, Horst DOLLINGER, Riccardo GIOVANNINI, Christoph HOENKE, Matthias HOFFMANN, Jan KRIEGL, Domnic MARTYRES, Georg RAST, Peter SEITHER
  • Piperidine-substituted indoles
    Patent number: 7759365
    Abstract: Disclosed are novel piperidine-substituted indoles- or heteroderivatives thereof of the formula 1: wherein R1, R5, R6, R7, A, B, D-E, Y, i, j, n and m are defined as below. The compounds of formula 1 are useful as agonists or antagonists of CCR-3. The present invention is also directed to pharmaceutically acceptable salts thereof, more particularly to provide pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one of the compounds of the present invention or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 26, 2006
    Date of Patent: July 20, 2010
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Domnic Martyres, Pascale Pouzet, Christoph Hoenke, Peter Seither, Silke Hobbie, Thierry Bouyssou
  • Antibodies to interleukin-like epithelial-mesenchymal transition inducer (ILEI)
    Patent number: 7745585
    Abstract: The functional characterization of ILEI to be a novel cytokine involved in epithelial/mesenchymal transition and the identification of biologically active ILEI provides the basis for generating ILEI inhibitors, in particular anti-ILEI antibodies, that are useful in the therapy of cancer, fibrosis and COPD.
    Type: Grant
    Filed: September 2, 2004
    Date of Patent: June 29, 2010
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Andreas Zophel, Horst Johann Ahorn, Birgit Jung, Renate Konopitzky, Karl-Heinz Heider, Norbert Kraut, Peter Seither, Thomas Waerner, Hartmut Beug, Martin Jechlinger, Ido M. Tamir, Andreas Weith, Stefan Gruenert
  • Cytokine involved in epithelial-mesenchymal transition
    Publication number: 20070089176
    Abstract: The functional characterization of ILEI to be a novel cytokine involved in epithelial/mesenchymal transition and the identification of biologically active ILEI provides the basis for generating ILEI inhibitors, in particular anti-ILEI antibodies, that are useful in the therapy of cancer, fibrosis and COPD.
    Type: Application
    Filed: September 2, 2004
    Publication date: April 19, 2007
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Andreas Zoephel, Horst Ahorn, Birgit Jung, Renate Konopitzky, Karl-Heinz Heider, Norbert Kraut, Peter Seither, Thomas Waerner, Hartmut Beug, Martin Jechlinger, Ido Tamir, Andreas Weith, Stefan Gruenert
  • Novel Piperidine-Substituted Indoles
    Publication number: 20060247230
    Abstract: Disclosed are novel piperidine-substituted indoles- or heteroderivatives thereof of the formula 1: wherein R1, R5, R6, R7, A, B, D-E, Y, i, j, n and m are defined as below. The compounds of formula 1 are useful as agonists or antagonists of CCR-3. The present invention is also directed to pharmaceutically acceptable salts thereof, more particularly to provide pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one of the compounds of the present invention or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 26, 2006
    Publication date: November 2, 2006
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Domnic Martyres, Pascale Pouzet, Christoph Hoenke, Peter Seither, Silke Hobbie, Thierry Bouyssou
  • Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
    Publication number: 20040253630
    Abstract: The present invention relates to substances which modulate receptors involved in inflammatory processes and whose modulated functions positively influence inflammatory diseases.
    Type: Application
    Filed: June 22, 2004
    Publication date: December 16, 2004
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Birgit Jung, Norbert Kraut, Stefan Mueller, Barbara Kistler, Peter Seither, Karsten Quast, Andreas Weith
  • Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
    Patent number: 6773895
    Abstract: The present invention relates to substances which modulate receptors involved in inflammatory processes and whose modulated functions positively influence inflammatory diseases.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: August 10, 2004
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Birgit Jung, Norbert Kraut, Stefan Mueller, Barbara Kistler, Peter Seither, Karsten Quast, Andreas Weith
  • Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
    Publication number: 20020119494
    Abstract: The present invention relates to substances which modulate receptors involved in inflammatory processes and whose modulated functions positively influence inflammatory diseases.
    Type: Application
    Filed: August 31, 2001
    Publication date: August 29, 2002
    Inventors: Birgit Jung, Norbert Kraut, Stefan Mueller, Barbara Kistler, Peter Seither, Karsten Quast, Andreas Weith